Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 2;6(10):001253.
doi: 10.12890/2019_001253. eCollection 2019.

Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome

Gemma Grau Gómez  1 , Oriol Giménez Campanario  2 , Nuria Pons Serra  2 , Mireia Cairó Llobell  1 , Pedro Almagro Mena  1
Affiliations

Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome

Gemma Grau Gómez et al. Eur J Case Rep Intern Med. .

Abstract

A 32-year-old woman undergoing an in vitro fertilization program was admitted to our hospital with the diagnosis of severe ovarian hyperstimulation syndrome (OHSS). Transvaginal ultrasonography showed two gestational sacs. Treatment with fluid restriction, serum albumin and intravenous furosemide was started, and repeated thoracentesis and paracenteses were performed. In the absence of clinical improvement, the patient was transferred to the intensive care unit and a therapeutic abortion was suggested. Due to the similarities between OHSS and idiopathic systemic capillary leak syndrome, we offered the patient compassionate treatment with intravenous immunoglobulins. After administration, the patient showed rapid improvement and we were able to suspend intravenous furosemide and serum albumin. She was discharged, and pregnancy has continued normally to date.

Learning points: OHSS is an infrequent yet serious complication of assisted reproductive treatment that involves increased capillary permeability.In severe refractory cases, immunoglobulins may be a useful and safe treatment to reverse this syndrome.

Keywords: Severe ovarian hyperstimulation syndrome; immunoglobulins.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interests: The Authors declare that there are no competing interest

References

    1. Selter J, Wen T, Palmerola KL, Friedman AM, Williams Z, Forman EJ. Life-threatening complications among women with severe ovarian hyperstimulation syndrome. Am J Obstet Gynecol. 2019;220(6):575. e1–575.e11. - PubMed
    1. Siddall E, Khatri M, Radhakrishnan J. Capillary leak syndrome: etiologies, pathophysiology, and management. Kidney Int. 2017;92:37–46. - PubMed
    1. Xie Z, Ghosh CC, Parikh SM, Druey KM. Mechanistic classification of the systemic capillary leak syndrome: Clarkson disease. Am J Respir Crit Care Med. 2014;189(9):1145–1147. - PMC - PubMed
    1. Pineton de Chambrun M, Gousseff M, Mauhin W, et al. Intravenous immunoglobulins improve survival in monoclonal gammopathy-associated systemic capillary-leak syndrome. Am J Med. 2017;130(10):1219. e19–1219.e27. - PubMed
    1. Almagro P, Martí JM, Garcia Pascual L, Rodriguez-Carballeira M. Successful treatment of systemic capillary leak syndrome with intravenous immunoglobulins. Rev Clin Esp. 2012;212(4):218–219. - PubMed

LinkOut - more resources